Literature DB >> 8198972

Spontaneous in vitro differentiation of a myoepithelial cell line (PA 16/23) from a pleomorphic adenoma of the parotid gland is associated with reduced production of the autocrine growth factor interleukin 6.

O Gallo1, D Bani, M G Giudizi, R Biagiotti, F Almerigogna, G Toccafondi, O Fini-Storchi, S Romagnani.   

Abstract

A myoepithelial cell line (PA 16/23) was derived from a pleomorphic adenoma of the parotid gland. PA 16/23 cells have light microscopic, immunophenotypical and ultrastructural features of immature myoepithelial cells, i.e. they are of fusiform or stellate shape and show keratin and actin cytofilaments located mainly in the perinuclear cytoplasm, desmosomes and tracts of basal lamina. The PA 16/23 cells grew actively and expressed mRNA for and produced interleukin 6 (IL-6) which was released into the culture medium. This cytokine, in turn, acted as an autocrine growth factor on the cells. PA 16/23 cells also expressed high-affinity IL-6 receptors. In these cells, both IL-6 production and proliferation could be modulated by exogenous stimulants, such as IL-6 itself, IL-1, IL-4, tumour necrosis factor alpha, interferon gamma and lipopolysaccharide. From the 40th culture passage onwards, the PA 16/23 cells ceased to grow, either spontaneously or in response to exogenous stimulants. Moreover, they strongly reduced IL-6 production, and underwent morphological differentiation into more mature myoepithelial cells, with an increased amount and a different arrangement of the keratin and actin cytofilaments, which formed thick bundles in the peripheral cytoplasm. These findings suggest a role for IL-6 in modulating the proliferation and, possibly, the differentiation of the PA 16/23 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198972      PMCID: PMC1969413          DOI: 10.1038/bjc.1994.209

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  33 in total

1.  Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6).

Authors:  G Tosato; K B Seamon; N D Goldman; P B Sehgal; L T May; G C Washington; K D Jones; S E Pike
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

2.  Interleukin-6. A multifunctional regulator of growth and differentiation.

Authors:  F Lee; C P Chiu; J Wideman; P Hodgkin; S Hudak; L Troutt; T Ng; C Moulds; R Coffman; A Zlotnik
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.

Authors:  R Kirnbauer; A Köck; T Schwarz; A Urbanski; J Krutmann; W Borth; D Damm; G Shipley; J C Ansel; T A Luger
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

4.  Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas.

Authors:  S Miki; M Iwano; Y Miki; M Yamamoto; B Tang; K Yokokawa; T Sonoda; T Hirano; T Kishimoto
Journal:  FEBS Lett       Date:  1989-07-03       Impact factor: 4.124

5.  IL-1 stimulates IL-6 production in endothelial cells.

Authors:  M Sironi; F Breviario; P Proserpio; A Biondi; A Vecchi; J Van Damme; E Dejana; A Mantovani
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

6.  Interleukin-6 immunoreactivity in human tumors.

Authors:  S S Tabibzadeh; D Poubouridis; L T May; P B Sehgal
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

7.  IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants.

Authors:  G Del Prete; E Maggi; P Parronchi; I Chrétien; A Tiri; D Macchia; M Ricci; J Banchereau; J De Vries; S Romagnani
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

8.  Interferon-beta 2/interleukin 6 is a co-stimulant for human T lymphocytes.

Authors:  G Tosato; S E Pike
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

9.  Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines.

Authors:  Z Walther; L T May; P B Sehgal
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

10.  Cytokine-induced production of IFN-beta 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 beta.

Authors:  S S Tabibzadeh; U Santhanam; P B Sehgal; L T May
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

View more
  2 in total

1.  Differentiation of breast cancer cells in vitro is promoted by the concurrent influence of myoepithelial cells and relaxin.

Authors:  D Bani; A Riva; M Bigazzi; T Bani Sacchi
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

Review 2.  Risk for COVID-19 infection in patients with tobacco smoke-associated cancers of the upper and lower airway.

Authors:  Oreste Gallo
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-11-20       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.